FR2391472A1 - Immunological haemolysis determn. of infections and immune processes - by selective haemolysis of damaged erythrocytes - Google Patents

Immunological haemolysis determn. of infections and immune processes - by selective haemolysis of damaged erythrocytes

Info

Publication number
FR2391472A1
FR2391472A1 FR7715227A FR7715227A FR2391472A1 FR 2391472 A1 FR2391472 A1 FR 2391472A1 FR 7715227 A FR7715227 A FR 7715227A FR 7715227 A FR7715227 A FR 7715227A FR 2391472 A1 FR2391472 A1 FR 2391472A1
Authority
FR
France
Prior art keywords
haemolysis
solution
serum
tested
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7715227A
Other languages
French (fr)
Other versions
FR2391472B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7715227A priority Critical patent/FR2391472A1/en
Publication of FR2391472A1 publication Critical patent/FR2391472A1/en
Application granted granted Critical
Publication of FR2391472B1 publication Critical patent/FR2391472B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/728—Bilirubin; including biliverdin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Abstract

A blood sample is mixed with sodium citrate soln; the mixture is mixed with a mixture of (a) a soln. made up of a boric acid soln. and a sodium citrate solution, (b) a dil. NaCl solution and (c), opt., a dil. or homeopathically prepd. solution of substances to be tested. After completion of the reactions the serum is separated off; and the serum is analysed, pref. for its bilirubin content. The solution of substances to be tested in isotonic saline is pref. diluted 1:1012. The substances to be tested can be synthetic cpds. or may be of animal, vegetable or mineral origin. They may also be antigens of known specificity. New agents for blood investigations comprise components (a), (b) and, optionally (c) above. The new procedure is specific for the haemolysis of erythrocytes. The rest is highly specific, accurate, generally applicable and quantitative. It can be carried out simply and cheaply, and is highly reliable. An example describes the use of the new procedure on samples of venous blood. The serum obtd. is subjected to bilirubin determin.
FR7715227A 1977-05-18 1977-05-18 Immunological haemolysis determn. of infections and immune processes - by selective haemolysis of damaged erythrocytes Granted FR2391472A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7715227A FR2391472A1 (en) 1977-05-18 1977-05-18 Immunological haemolysis determn. of infections and immune processes - by selective haemolysis of damaged erythrocytes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7715227A FR2391472A1 (en) 1977-05-18 1977-05-18 Immunological haemolysis determn. of infections and immune processes - by selective haemolysis of damaged erythrocytes

Publications (2)

Publication Number Publication Date
FR2391472A1 true FR2391472A1 (en) 1978-12-15
FR2391472B1 FR2391472B1 (en) 1980-04-04

Family

ID=9190986

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7715227A Granted FR2391472A1 (en) 1977-05-18 1977-05-18 Immunological haemolysis determn. of infections and immune processes - by selective haemolysis of damaged erythrocytes

Country Status (1)

Country Link
FR (1) FR2391472A1 (en)

Also Published As

Publication number Publication date
FR2391472B1 (en) 1980-04-04

Similar Documents

Publication Publication Date Title
LV10538A (en) Influence of immunologically binding agent on biological fluid and diagnostic agent
JPS6454260A (en) Immunological analysis for ck-mm cardiac infarction
ES2009939A6 (en) Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans.
NO930770L (en) IMMUNOLOGICAL PROCEDURE FOR DETERMINING A HEMOGLOBIN DERIVATIVE
DK622788D0 (en) METHOD OF ANALYSIS AND TEST SYSTEM FOR DETERMINING THE RELATIVE QUANTITY OF A PARTICULAR HAEMOGLOBIN DERIVATIVE IN A BLOOD SAMPLE
FI84107C (en) HbA1c immunological assay comprising denaturin g
ES2058212T3 (en) LATEX AGGLUTINATION IMMUNO ASSAY IN THE PRESENCE OF HEMOGLOBIN.
SE7614183L (en) PROCEDURE AND DEVICE FOR PREGNANCY TESTS
ES352693A1 (en) Product for and method of testing blood for the presence of hemoglobin s
Shivers et al. Some properties of pig follicular fluid
ES507947A0 (en) PROCEDURE TO DETERMINE THE CONCENTRATION OF GLUCOSE IN A TEST SAMPLE.
HUT57902A (en) Method and reagent for detecting hemoglobin
Stevens et al. Immunochemical and electrophoretic properties of oestrous rabbit uterine fluid proteins obtained by uterine ligation
SE7704359L (en) PROCEDURE FOR ENRICHMENT OF A PLACENTAS-SPECIFIC GLYCOPROTEIN
NL7704891A (en) Immunological haemolysis determn. of infections and immune processes - by selective haemolysis of damaged erythrocytes
FR2391472A1 (en) Immunological haemolysis determn. of infections and immune processes - by selective haemolysis of damaged erythrocytes
ES2088427T3 (en) SIMULTANEOUS TEST OF TWO ANALYTIES.
JPS5742852A (en) Erythrocyte sensitized with antibody of polysaccharide of hemolytic streptococcus
GB1294518A (en) Test kit for use in the determination of uric acid in blood serum
NO175024C (en) Agglutination reagent and its use for detecting an antigen, antibodies or other analytes, and testing comprising the reagents
JPS5794659A (en) Hemolysis of continuously measuring streptolysin o antibody in blood sample or serum sample byuse of streptolysin oxide o
ATE78342T1 (en) METHODS OF DETECTING PREGNANCY DISORDERS.
JPS5218815A (en) Novel method of immunological clinical diagnosis by means of gel-preci pitation
JPS5480410A (en) Corpuscle sensitized with anti-human-albumin-antibody, its preparation, and determination of human albumin using the same
ES496099A0 (en) PROCEDURE FOR THE MANUFACTURE OF INDICATORS FOR GO-NADOTROPIN CHORONIC HUMAN

Legal Events

Date Code Title Description
ST Notification of lapse